Advertisement
New Zealand markets close in 1 hour
  • NZX 50

    11,829.31
    -117.12 (-0.98%)
     
  • NZD/USD

    0.5958
    +0.0009 (+0.14%)
     
  • NZD/EUR

    0.5550
    +0.0010 (+0.18%)
     
  • ALL ORDS

    7,847.90
    -89.60 (-1.13%)
     
  • ASX 200

    7,586.50
    -96.50 (-1.26%)
     
  • OIL

    83.83
    +0.26 (+0.31%)
     
  • GOLD

    2,345.00
    +2.50 (+0.11%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,589.97
    +305.43 (+1.77%)
     
  • NIKKEI 225

    37,906.08
    +277.60 (+0.74%)
     
  • NZD/JPY

    92.8890
    +0.3930 (+0.42%)
     

Vital Healthcare Property Trust (NZSE:VHP) insider upped their holding by 8.2% earlier this year

Insiders were net buyers of Vital Healthcare Property Trust's (NZSE:VHP ) stock during the past year. That is, insiders bought more stock than they sold.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

See our latest analysis for Vital Healthcare Property Trust

The Last 12 Months Of Insider Transactions At Vital Healthcare Property Trust

In the last twelve months, the biggest single purchase by an insider was when insider Andrew Evans bought NZ$146k worth of shares at a price of NZ$2.90 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being NZ$2.82). It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price. The only individual insider to buy over the last year was Andrew Evans.

ADVERTISEMENT

Andrew Evans bought a total of 55.68k shares over the year at an average price of NZ$2.91. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership

Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Our data suggests Vital Healthcare Property Trust insiders own 0.1% of the company, worth about NZ$2.6m. I generally like to see higher levels of ownership.

So What Do The Vital Healthcare Property Trust Insider Transactions Indicate?

It doesn't really mean much that no insider has traded Vital Healthcare Property Trust shares in the last quarter. However, our analysis of transactions over the last year is heartening. We'd like to see bigger individual holdings. However, we don't see anything to make us think Vital Healthcare Property Trust insiders are doubting the company. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Our analysis shows 5 warning signs for Vital Healthcare Property Trust (2 can't be ignored!) and we strongly recommend you look at them before investing.

Of course Vital Healthcare Property Trust may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.